Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia

被引：0
|
作者：
Siami, K [1 ]
Awagu, S [1 ]
Cooper, DG [1 ]
Thomas, DA [1 ]
Huh, Y [1 ]
Jones, D [1 ]
Chen, W [1 ]
Jorgensen, JL [1 ]
机构：
[1] UTMDACC, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1143
引用
收藏
页码：246A / 247A
页数：2
相关论文
共 50 条
  • [1] Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia
    Siami, K
    Awagu, S
    Cooper, DG
    Thomas, SA
    Huh, Y
    Jones, D
    Chen, W
    Jorgensen, JL
    MODERN PATHOLOGY, 2006, 19 : 246A - 247A
  • [2] EVALUATION OF NEW MARKERS FOR FLOW CYTOMETRIC MONITORING OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Sedek, L.
    Sonsala, A.
    Twardoch, M.
    Van der Velden, V. H.
    Orfao, A.
    Mejstrikova, E.
    Szczepanski, T.
    HAEMATOLOGICA, 2014, 99 : 544 - 545
  • [3] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2018, 131 (14) : 1522 - 1531
  • [4] FLOW CYTOMETRIC EVALUATION OF MINIMAL RESIDUAL DISEASE ON DAY 15 OF INDUCTION TREATMENT IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Sedek, Lukasz
    Sonsala, Alicja
    Bulsa, Joanna
    Wieczorek, Maria
    Malinowska, Iwona
    Derwich, Katarzyna
    Trelinska, Joanna
    Muszynska-Roslan, Katarzyna
    Badowska, Wanda
    Niedzwiecki, Maciej
    Niedzielska, Ewa
    Sobol, Grazyna
    Wysocki, Marek
    Kowalczyk, Jerzy
    Mazur, Bogdan
    Szczepanski, Tomasz
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 411 - 412
  • [5] Morphological and immunological criteria of minimal residual disease detection in children with B-cell precursors acute lymphoblastic leukemia
    Beznos, O. A.
    Grivtsova, L. Yu
    Popa, A., V
    Shervashidze, M. A.
    Serebtyakova, I. N.
    Tupitsyn, N. N.
    Selchuk, V. U.
    Grebennikova, O. P.
    Titova, G., V
    VI INTERNATIONAL SCIENTIFIC SCHOOL-CONFERENCE OF YOUNG SCIENTISTS MODERN PROBLEMS OF PHYSICS AND TECHNOLOGIES, 2018, 945
  • [6] Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia
    Dworzak, MN
    Panzer-Grümayer, ER
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1445 - 1455
  • [7] Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia
    LandmanParker, J
    Aubin, J
    Delabesse, E
    Tabone, MD
    Adam, M
    Millien, C
    Leboeuf, D
    BuzynVeil, A
    Dollfus, C
    Leverger, G
    Macintyre, EA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (02) : 281 - 290
  • [8] Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype
    Mlcáková, A
    Babusíková, O
    NEOPLASMA, 2003, 50 (06) : 416 - 421
  • [9] CD81 is aberrantly underexpressed by most precursor B-cell acute lymphoblastic leukemias: Implications for flow cytometric minimal residual disease assays
    Jorgensen, J. L.
    Brahmandam, A.
    Thomas, D. A.
    LABORATORY INVESTIGATION, 2007, 87 : 247A - 247A
  • [10] CD81 is aberrantly underexpressed by most precursor B-Cell acute lymphoblastic leukemias: Implications for flow cytometric minimal residual disease assays
    Jorgensen, J. L.
    Brahmandam, A.
    Thomas, D. A.
    MODERN PATHOLOGY, 2007, 20 : 247A - 247A
12345